Sort by
Refine Your Search
-
, the hypothesis is that progression risk of pre-AML, as well as relapse risk of AML, can be predicted from properties of (pre-)leukemic clones. We count with a strong network of clinical collaborators
Enter an email to receive alerts for network-analysis "https:" positions